Brief: Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
05/12/2024 14:21
Dec 5 (Reuters) - Hyperfine Inc HYPR.O :
* HYPERFINE ANNOUNCES EXTENSIVE CLINICAL STUDY COVERAGE AT
RSNA
2024, SHOWCASING THE BODY OF EVIDENCE SUPPORTING THE USE OF THE
SWOOP® SYSTEM ACROSS DIFFERENT SITES OF CARE
Source text: ID:nBwzxRC6a
Further company coverage: HYPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsPortable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Brief: Hyperfine, Inc. Q3 Sales USD 6 Million
Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
Portable MRI maker Hyperfine's Q2 revenue rises less than expected
Brief: Hyperfine, Inc. Q2 EPS USD -0.09